(1)
INTERNATIONAL CONFERENCE ON HARMONISATION GUIDELINES ON THE LIMITS OF GENOTOXIC IMPURITIES IN DRUG PRODUCT. Int. Res. J. Pharm. 2012, 3 (4), 160-163.